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during Apoptosis, Interacts Selectively
with the Atypical Isoforms of Protein Kinase C
Marı´a T. Dı´az-Meco, Marı´a M. Municio, Sonia Frutos, impairs cell proliferation (Berra et al., 1993), mitogen-
activated protein kinase (MAPK) activation (Berra et al.,Pilar Sanchez, Jose´ Lozano, Laura Sanz,
and Jorge Moscat 1995), and kB-dependent promoter activity (Diaz-Meco
et al., 1993, 1996; Dominguez et al., 1993; Folgueira etCentro de Biologı´a Molecular
Consejo Superior de Investigaciones Cientı´ficas al., 1996).
The major divergences in the sequence between theUniversidad Auto´noma de Madrid
Canto Blanco atypical PKC subfamily and the classical or novel PKCs
are located in the regulatory domain. The identification28049 Madrid
Spain of selective modulators for each PKC isotype will be
of great help in the understanding of the function and
regulation of the different PKC isoforms. In this regard,
we have recently identified a novel protein, namedSummary
l-interacting protein (LIP), that is a selective activator
of l/iPKC (Diaz-Meco et al., 1996). LIP binds to the zincThe atypical PKCs are involved in a number of impor-
finger of l/iPKC, but does not bind to aPKC, ePKC, ortant cellular functions, including cell proliferation. We
even the highly related zPKC (Diaz-Meco et al., 1996).report here that the product of the par-4 gene specifi-
Interestingly, overexpression of LIP stimulates kB-cally interacts with the regulatory domains of zPKC
dependent promoter activity (Diaz-Meco et al., 1996),and l/iPKC, which dramatically inhibits their enzy-
emphasizing the functional importanceof this PKC regu-matic activity. This is particularly challenging, because
lator. Although the products of phosphatidylinositol (PI)expression of par-4 has been shown to correlate with
3-kinase activate zPKC and l/iPKC (Nakanishi et al.,growth inhibition and apoptosis. Results are shown
1993; Akimoto et al., 1996), they also stimulate otherhere demonstrating that the expression of par-4 in
kinases such as ePKC (Moriya et al., 1996), hPKC, (TokerNIH-3T3 cells induces morphological changes typical
et al., 1994), PRK1 (Palmer et al., 1995), and c-Aktof apoptosis, which are abrogated by cotransfection
(Franke et al., 1995). Ceramide activates both zPKC andof either wild-type zPKC or l/iPKC, but not by their
l/iPKC (Lozano et al., 1994; Mu¨ller et al., 1995), butrespective kinase-inactive mutants. These findings
it does also stimulate the ceramide-activated proteinsupport a role for the atypical PKC subspecies in the
kinase (Yao et al., 1995; Zhang and Kolesnick, 1995)control of cell growth and survival.
among other possible targets. This strongly indicates
that the different lipid mediators are not selective forIntroduction
a given PKC. The fact that LIP specifically binds and
activates the l/iPKC isoform suggests that the specific-The atypical subgroup of the protein kinase C (PKC)
ity of the regulation of the different PKC isotypes willfamily of isozymes is composed of two members:
most probably be mediated by protein regulators. The
l/iPKC and zPKC (Akimoto et al., 1994; Ohno et al.,
molecular characterization of those proteins would1989; Selbie et al., 1993). iPKC is the human homolog
allow the dissection of specific pathways controlled byof the mouse l, and both show a high degree of homol-
the different PKC isotypes. In this study, we have usedogy in the catalytic as well as the regulatory domain
the regulatory domain of zPKC as the “bait” to identifywith zPKC from different species (Nishizuka, 1992). Con-
potentially novel regulators of its kinase activity by thetrary to other PKC isoforms, the atypicals cannot be
two-hybrid system. We report here that the product ofregulated by Ca21, phorbol esters, or diacylglycerol (Aki-
the par-4 gene specifically interacts with the zinc fingermoto et al., 1994; Ohno et al., 1989; Selbie et al., 1993;
domain of zPKC and l/iPKC and that it dramaticallyWays et al., 1992), but are regulated by other lipid cofac-
inhibits their enzymatic activity. Expression of par-4 hastors such as phosphatidylinositol (3,4,5)trisphosphate
been shown to correlate with growth inhibition andand ceramide (Lozano et al., 1994; Nakanishi and Exton,
apoptosis (Sells et al., 1994). Results are shown here1992; Nakanishi et al., 1993), which aregenerated follow-
that strongly support a role for the atypical PKCs in theing cell activation by inflammatory cytokines and growth
control of cell proliferation and survival.factors (Hannun, 1994; Kolesnick and Golde, 1994; Ex-
ton 1994; Liscovitch and Cantley, 1994). Consistent with
this, the atypical PKCs l/i and z are involved in a number Results
of important cellular functions. Thus, microinjection of
an inhibitor peptide with the sequence of the pseudo- Yeast Two-Hybrid Assays
The regulatory domain of zPKC (amino acids 1–250) wassubstrate of the atypical PKC isotypes, but not of aPKC
or ePKC, dramatically inhibited maturation (Dominguez fused with the DNA-binding domain of the yeast LexA
protein (pBTM116zPKCREG) to serve as the bait to screenet al., 1992) and NF-kB activation (Dominguez et al.,
1993) in Xenopus oocytes, as well as the reinitiation of a human placenta Matchmaker cDNA library. We se-
lected colonies that grew on yeast dropout media lack-DNA synthesis in quiescent mouse fibroblasts (Berra et
al., 1993). Also, down-regulation of zPKC with antisense ing leucine, tryptophan, and histidine but containing 20
mM 3-amino-1,2,4-triazole and that were blue withinoligonucleotides or transfection of a kinase-inactive
dominant-negative mutant of l/iPKC or zPKC severely 20 min when assayed by X-Gal colony filter assay. We
Cell
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Figure 1. Specificity of the Interaction of
Par-4 with zPKCREG
The Saccharomyces cerevisiae SFY526 re-
porter host strain was transformed with the
following plasmids.
(A) pGAD10-Par-4 and pYTH9 (a); pYTH9zPK-
CREG (b); pYTH9l/iPKCREG (c); pYTH9zPKCCAT
(d); pYTH9zPKC126 (e); pYTH9zPKCZF (f);
pYTH9zPKCREG-C167S (g); pYTH9l/iPKC126 (h);
pYTH9ePKCREG (i); pYTH9aPKCREG (j).
(B) pGAD10-Par-4 and pYTH9zPKCREG (a);
pYTH9zPKCZF (b); pYTH9zPKC126 (c); pYTH9-
Par-4 (d); pGBT9RafREG (e); pGBT9RafCAT
(f); pGBT9Mos (g) or pGAD10-Par-4D and
pYTH9zPKCREG (h); pYTH9zPKCZF (i); pYTH9-
Par-4 (j).
Individual Leu1 Trp1 transformants were
streaked to synthetic medium plates lacking
tryptophan, leucine, and histidine. The plates
were incubated at 308C for 3 days. Essentially
identical results were obtained in another two
experiments.
obtained 5 positive colonies that stained intensely blue fails to transactivate the reporter constructs (Table 1).
The catalytic domain of zPKC did not interact with Par-4,from 2.5 3 106 screened. The expression of His-3 and
whereas the full-length zPKC, as well as the regulatoryLacZ in these colonies was shown to depend on the
domain of l/iPKC, did show interaction (Figure 1; TableLexA fusion protein by retransforming the recovered
1). Interestingly, Par-4 does not interact with the regula-plasmids into yeasts containing the bait construct (Fig-
tory domains of aPKC or ePKC (Figure 1; Table 1), indi-ure 1; Table 1). The sequences of the 5 clones revealed
cating that it is highly specific for the atypical PKC iso-that they were identical and corresponded to a partial
types. On the other hand, Raf-1 is a serine/threoninecDNA coding for the last 272 amino acids (positions
kinase with an overall structure similar to that of the60–332) of the previously cloned par-4, which has been
atypical PKCs (Ohno et al., 1989). Both types of kinasesidentified as a gene induced during apoptosis (Sells et
are critical components downstream of Ras in mitogenical., 1994). Owing to the role of zPKC in mitogenic signal-
cascades (Berra et al., 1993; Howe et al., 1992). There-ing (see Introduction), this finding could be of great rele-
fore, it was of great interest to determine whether Raf-1vance. Therefore, the specificity of the interaction be-
would interact with Par-4. Neither full-length Raf-1 nortween zPKCREG and the par-4 gene product was next
the catalytic domain or the regulatory region of Raf-1tested with an unrelated molecule, pGBT9Lamin, which
interacted with Par-4 (Figure 1; Table 1). The product of
c-mos, which is another serine/threonine kinase criti-
Table 1. b-Galactosidase Activity Induced by Interaction cally involved (like Raf-1 and the atypical PKCs) in mito-
between the Regulatory Domain of zPKC and Par-4 genic signal transduction in Xenopus oocytes and mam-
malian cells (Sagata et al., 1988), did not interact withGAL4 Activation Domain
Fusion (Blue) Par-4 (Figure 1; Table 1). Therefore, these data collec-
tively indicate that Par-4 specifically binds to the regula-GAL4 Binding Domain Fusion pGAD10 pGAD10-Par-4
tory domain of zPKC and l/iPKC, but not to other struc-
pYTH9 2 2 turally and functionally related kinases. To map the
pYTH9l/iPKCREG 2 1
region in the regulatory domain of zPKC where Par-4pYTH9zPKCREG-C167S 2 2
binds, we fused cDNA fragments corresponding topYTH9zPKCCAT 2 2
amino acids 1–126 and 127–194 (corresponding to thepYTH9zPKCREG 2 1
zinc finger region) of zPKC or l/iPKC with the DNA-pYTH9zPKC 2 1
pYTH9zPKC126 2 2 binding domain of the yeast GAL4 protein and deter-
pYTH9l/iPKC126 2 2 mined their ability to interact with Par-4 in the two-
pYTH9zPKCZF 2 1 hybrid system. Of note, only the zinc finger and the
pYTH9l/iPKCZF 2 1
whole regulatory domain of zPKC and l/iPKC displayedpYTH9aPKCREG 2 2
Par-4 binding activity (Figure 1; Table 1). Interestingly,pYTH9ePKCREG 2 2
disruption of the cysteine finger by mutation of Cys-pGBT9Raf CAT 2 2
pGBT9Raf 2 2 167 to serine in the zPKC regulatory domain completely
pGBT9Mos 2 2 abolished the binding of Par-4 (Figure 1; Table 1). The
pGBT9Lamin 2 2 deduced amino acid sequence of par-4 predicts a
coiled-coil leucine zipper at the C-terminal part of theb-Galactosidase activity was determined by a filter assay for the
yeast strains containing the indicated plasmids, as described in protein (Sells et al., 1994). Interestingly, this is located
Experimental Procedures. Plus represents a positive indication of in a region that shows a significant degree of homology
b-galactosidase activity (blue color) using filter assays. Essentially with the death domain of proteins that are critically in-
identical results were obtained in three other independent experi- volved in the induction of apoptosis (Chinnaiyan et al.,
ments.
1995; Cleveland and Ihle, 1995; Hsu et al., 1995; Stanger
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Figure 2. Alignment of Different Death Domains
Amino acids 248–330 of Par-4 are compared with the death domains of Fas, TNFR1 (TR1), TNFR1-associated death domain protein (TRADD),
Fas-associating protein with death domain (FADD), and receptor-interacting protein (RIP). Shaded letters indicate amino acids that are
conserved in Par-4, as described in Cleveland and Ihle (1995).
et al., 1995). Thus, the alignment of the Par-4 C-terminal fusion proteins and immobilized on amylose beads,
were incubated with radiolabeled in vitro translatedregion with the death domains of Fas, RIP, FADD,
TRADD, and the tumor necrosis factor receptor 1 zPKC. As expected, zPKC interacted with MBP–Par-4
but not with MBP–Par-4D or MBP alone (Figure 3A). To(TNFR1) using the CLUSTAL program of the PCGene
package gives a pairwise similarity score for Par-4 with investigate further the interaction between Par-4 and
zPKC, we incubated MBP–Par-4, MBP–Par-4D, or MBPFas and TRADD of 15 and 13, respectively. Although
lower than that displayed by TRADD with TNFR1 (19), with the regulatory domain of zPKC or its zinc finger
mutant zPKCREG-C167S, which were expressed as glutathi-this score is identical to that given by Fas with FADD,
TNFR1, or TRADD (15). Also of note, the pairwise similar- one S-transferase (GST) fusion proteins (Figure 3B). Two
different concentrations (100 or 400 nM) of the MBPity score for Par-4 with Fas and TRADD is higher than
that for TRADD with RIP or FADD (12). Alignment of fusion proteins were incubated with 800 nM GST fusion
proteins for 1 hr at 48C, after which MBP, MBP–Par-4,Par-4 residues 248–330 relative to residues 230–307 of
Fas results in a 43% homology and 29% identity (Figure and MBP–Par-4D were immobilized on amylose resin.
Following extensive washing with binding buffer plus2). This is comparable with that resulting from the align-
ment of, for example, TRADD with TNFR1 (23% identity; 0.1% Triton X-100, bound MBP fusion proteins and any
associated proteins were boiled in sample buffer, frac-Cleveland and Ihle, 1995). However, the residue corre-
sponding to Val-238 of Fas, which when mutated to tionated by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), and immunoblotted with anti-GST anti-asparagine abolishes cell death induction, is not con-
served in Par-4 (Figure 2). It should be stressed that this body to detect binding of the different GST fusion pro-
teins to Par-4. Of note, GST–zPKCREG but not GST–residue is not conserved in other cell death proteins
such as Reaper or RIP (Cleveland and Ihle, 1995). In the zPKCREG-C167S or GST bound to MBP–Par-4 (Figure 3B).
Also, no binding was detected of the GST fusion proteinsnext series of experiments, this region of Par-4 was
deleted and the ability of this mutant to interact with to MBP–Par-4D or MBP alone (Figure 3B). Similar results
were obtained in experiments using GST–l/iPKCREGthe regulatory domain of zPKC was tested in the two-
hybrid system. According to the results of this experi- (data not shown). Staining of a parallel gel confirms that
all the reactions contained equal molar amounts of GSTment, Par-4 homodimerizes (Table 2), but deletion of
the C-terminal region completely abrogates thehomodi- and MBP fusion proteins (data not shown).
merization, as well as the interaction with the regulatory
domain of zPKC (Table 2) or l/iPKC (data not shown).
Inhibition of zPKC by Par-4This represents evidence that the zinc finger domain of
Because Par-4 binds specifically to the zinc finger ofa PKC interacts with a leucine-zipper motif.
zPKC and l/iPKC and that region has been shown to
mediate the binding of regulators (Diaz-Meco et al.,Binding of Par-4 to zPKC In Vitro
1996; Nishizuka, 1992; Quest and Bell, 1994), we soughtTo confirm the interaction observed in yeast, Par-4 and
to determine whether the interaction of Par-4 with zPKCPar-4D, expressed as maltose-binding protein (MBP)
can modulate its enzymatic activity in vitro. Therefore,
serum-starved COS cells were transfected with influ-
Table 2. b-Galactosidase Activity Induced by Interaction enza hemagglutinin (HA) protein epitope–tagged zPKC
between the Wild-Type and Mutant Par-4 and the Regulatory
or l/iPKC, and the expressed protein was immunopuri-Domain of zPKC
fied with the anti-HA monoclonal antibody 12CA5. The
GAL4 Activation Domain Fusion (Blue) addition of phosphatidylserine (a classical activator of allGAL4 Binding
Domain Fusion pGAD10 pGAD10-Par-4 pGAD10-Par-4D PKCs) to the immunoprecipitates significantly activated
zPKC (Figure 3C). Interestingly, the addition of 1 mg ofpYTH9 2 2 2
MBP–Par-4, but not of MBP alone, produced a dramaticpYTH9zPKCREG 2 1 2
reduction of zPKC (Figure 3C) and l/iPKC (data notpYTH9zPKCZF 2 1 2
pYTH9-Par-4 2 1 2 shown) activities. MBP–Par-4 produced no effect on the
activity of a highly purified preparation of classical PKCsb-Galactosidase activity was determined by a filter assay for the
(data not shown). Therefore,Par-4 not only binds specifi-yeast strains containing the indicated plasmids, as described in
Experimental Procedures. Plus represents a positive indication of cally to the zinc finger of zPKC and l/iPKC, but it is also
b-galactosidase activity (blue color) using filter assays. Essentially a potent inhibitor of their kinase activity. As a control,
identical results were obtained in three other independent experi- it was shown that the Par-4D mutant expressed as an
ments.
MBP fusion protein (MBP–Par-4D), which we showed
Cell
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Figure 3. Interaction of Par-4 with zPKC In
Vitro and In Vivo
(A) Purified MBP, MBP–Par-4, or MBP–Par-
4D (400 nM) was incubated with in vitro trans-
lated 35S-labeled zPKC at 48C for 1 hr. The
recombinant proteins recovered onto amy-
lose beads were fractionated by SDS–PAGE,
followed by autoradiography in an Instant-
Imager. Essentially identical results were ob-
tained in another two experiments.
(B) Purified GST or GST fusion proteins en-
coding the regulatory domain of zPKC (GST–
zPKCREG) or its zinc finger mutant (GST–
zPKCREG-C167S) at a concentration of 800 nM
were incubated with either 100 or 400 nM
MBP fusion proteins for 1 hr at 48C, after
which the MBP fusion proteins were immobi-
lized on amylose resin. MBP fusion proteins
and any associated proteins were boiled in
sample buffer, fractionated by SDS–PAGE,
and immunoblotted with anti-GST antibody
to detect binding of the different GST fusion
proteins. Essentially identical results were
obtained in another two experiments.
(C) COS cells were transfected with either
control plasmid or an expression vector for
HA-tagged zPKC, after which they weremade
quiescent by serum starvation, and the ex-
pressed proteins were immunoprecipitated
with an anti-HA antibody. Afterward, the ef-
fect of 1 mgof MBP,MBP–Par-4, or MBP–Par-
4D on the unstimulated or phosphatidylser-
ine-activated (50 mg/ml) enzymatic activity of HA-zPKC was determined with hnRNPA1 as substrate. Essentially identical results were obtained
in another two experiments.
(D) Subconfluent cultures of COS cells in 100 mm plates were transfected with 20 mg of either pCDNA3 (control), pCDNA3-HA-Par-4 (HA-
Par-4), or pCDNA3-HA-Par-4D (HA-Par-4D). Plasmid DNA was removed 4 hr later, and cells were incubated in DMEM containing 10% FCS
for 36 hr. Cell extracts (50 mg of protein) were immunoprecipitated with anti-HA antibody. The extract lane contains 20 mg of protein cell
extract. Immunoprecipitates were resolved by SDS–PAGE and immunoblotted with an anti-zPKC antibody. Essentially identical results were
obtained in another two experiments.
(E) NIH-3T3 cells were induced to apoptosis by UV irradiation. Afterward, they were extracted at different times and immunoprecipitated with
anti-zPKC antibody, and the enzymatic activity was determined using hnRNPA1 as substrate. Essentially identical results were obtained in
another two experiments.
above does not interact with zPKC, was unable to inhibit extracts were immunoprecipitated 4 hr after UV treat-
ment with the anti-Par-4 antibody, which was eitherzPKC activity (Figure 3C).
untreated or preabsorbed with MBP or MBP–Par-4. Im-
munoblot analysis of the immunoprecipitates with anti-Binding of Par-4 to zPKC In Vivo
Par-4 and anti-zPKC antibody shows that UV irradiationTo determine whether Par-4 interacts in vivo with zPKC,
induces the expression of Par-4, which coimmunopreci-we transfected COS cells with either control plasmid,
pitates with zPKC (Figure 4). When the anti-Par-4 anti-HA-tagged par-4, or HA-tagged par-4D expression
body was preadsorbed with MBP–Par-4 but not withvectors. Cell lysates were immunoprecipitated with an
MBP, the Par-4 protein was not immunoprecipitated,anti-HA monoclonal antibody 40 hr posttransfection. Im-
and zPKC was absent (Figure 4). UV irradiation inducesmunoprecipitates were resolved by SDS–PAGE and an-
Par-4 at the gene transcriptional level (data not shown).alyzed by immunoblotting with an antibody against
Collectively, these results indicate that Par-4 binds tozPKC. An immunoreactive band corresponding to zPKC
zPKC in vitro and in vivo and that this association leadswas clearly detected in immunoprecipitates only from
to a dramatic inhibition of the kinase activity.cells transfected with the HA-par-4 vector and not with
the empty plasmid or with HA-par-4D (Figure 3D). Immu-
noblot analysis with anti-aPKC antibody revealed the Expression of Par-4 Inhibits AP1-Dependent
Promoter Activitylack of association of native aPKC with Par-4 (data not
shown). To determine whether native Par-4 interacts Since zPKC and l/iPKC are critically involved in the
transactivation of AP1-dependent promoters (Akimotowith native zPKC in vivo, we used the MBP–Par-4 fusion
protein to immunize rabbits and generate an antibody et al., 1996; Bjorkoy et al., 1995), it was of great interest
to determine the effect of par-4 transfection on thatagainst Par-4. Next, NIH-3T3 cells were induced to un-
dergo apoptosis by ultraviolet (UV) irradiation (Brancolini parameter. Results from Figure 5A demonstrate that the
transfection of a par-4 expression vector dramaticallyet al., 1995), which was confirmed by measuring DNA
fragmentation of parallel cultures (data not shown). Cell inhibits the activation by serum of an AP1 enhancer–
Atypical PKCs and Apoptosis
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Figure 4. Interaction of Par-4 with zPKC In Vivo
Cell protein from NIH-3T3 cells (100 mg), either induced to undergo
apoptosis by UV irradiation (lanes 1–3) or untreated (lane 4), were
immunoprecipitated with anti-Par-4 antibody that was either un-
treated (lanes 1 and 4) or preadsorbed with MBP (lane 2) or MBP–
Par-4 (lane 3). Immunoprecipitates were fractionated by SDS–PAGE
and immunoblotted with anti-Par-4 (lower) or anti-zPKC (upper) anti-
bodies. Essentially identical results were obtained in another two
experiments.
directed luciferase reporter plasmid in a dose-depen-
dent manner (Figure 5A). As a control, transfection of
par-4 produces little or no effect on a constitutive cyto-
megalovirus (CMV)promoter-based reportervector (Fig-
ure 5A). Transfection of par-4D expression vector did
not inhibit AP1 promoter activity (Figure 5B), consistent
with its lack of effect on the atypical PKCs. Cotransfec-
tion of expression plasmid for l/iPKC, but not for aPKC,
significantly suppressed the inhibition by Par-4 of the
AP1 promoter activity (Figure 5C). All of the above indi-
cates that the inhibition of the atypical PKCs by Par-4
is of physiological relevance.
Figure 5. Transfection of a par-4 Expression Vector Inhibits Serum-
Induced AP1 Promoter Activity
Expression of Par-4 Induces Apoptosis in a
(A) NIH-3T3 cells were transfected with different concentrations of
zPKC- and l/iPKC-Dependent Manner plasmid pCDNA3-HA-par-4 along with 500 ng of the AP1 enhancer–
Because par-4 has been shown to be induced in cells directed luciferase reporter plasmid (AP1-luc) or a constitutive CMV-
undergoing apoptosis (Sells et al., 1994; Figure 4), a directed luciferase reporter (CMV-luc). After 4 hr, the DNA-con-
taining medium was removed and cells were made quiescent bymodel can be proposed whereby the inducers of pro-
serum starvation for 24 hr. Following stimulation with serum (20%grammed cell death promote the expression of Par-4,
FCS for 4 hr), extracts were prepared and the luciferase activity waswhich selectively interacts with and inhibits the atypical
determined as described in Experimental Procedures. Results are
PKCs. This suggests that zPKC and l/iPKC may be the mean 6 SD of three independent experiments with incubations
critically involved in the generation of survival signals. To in duplicate.
test this hypothesis, we initially used a b-galactosidase (B) As in (A), but transfecting pCDNA3-HA-par-4D. Results are the
mean 6 SD of three independent experiments with incubations intransfection assay to determine cell viability (Hsu et al.,
duplicate.1995). NIH-3T3 cells transfected with an expression vec-
(C) As in (A), but cotransfected with 10 mg of expression vectors fortor for a kinase-inactive dominant-negative mutant of
l/iPKC or aPKC. The level of expression of both kinases was always
zPKC or l/iPKC (Berra et al., 1995; Diaz-Meco et al., comparable by immunoblot. Results are the mean 6 SD of three
1996) gave a dramatic reduction in the number of independent experiments with incubations in duplicate.
b-galactosidase-positive (blue) cells, as compared with
cells transfected with a control plasmidor an expression
vector for wild-type zPKC or l/iPKC (Table 3). Interest- Par-4 as well as of l/iPKCMUT provokes DNA fragmenta-
tion consistent with the induction of apoptosis. Of note,ingly, transfection of par-4 but not par-4D also provoked
a dramatic reduction in the number of blue cells, indicat- the induction of apoptosis by l/iPKCMUT does not induce
Par-4 (data not shown), consistent with the notion thating that inhibition of the atypical PKCs triggers cell death
(Table 3). Cotransfection of wild-type zPKC or l/iPKC the atypical PKCs are critical downstream targets of
Par-4. Transfection of Par-4D produces no effect on(but not of their respective kinase-inactive mutants) with
par-4 increased the number of blue cells. This supports this parameter, and cotransfection of wild-type l/iPKC
significantly suppresses DNA fragmentation induced bythe notion that the mechanism by which par-4 promotes
cell death critically involves inhibition of the atypical Par-4 (Figure 6). In addition, overexpression of Par-4
induces morphological changes that are typical ofPKCs. The results in Figure 6 show that expression of
Cell
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Table 3. Cell Death Induced by Dominant-Negative zPKC, Par-4 Expression, and UV Irradiation
Number of Blue Cells per Well
Control zPKC zPKCMUT l/iPKC l/iPKCMUT
Control 3050 6 280 4120 6 310 325 6 75 3800 6 400 420 6 50
Par-4 205 6 50 2500 6 320 110 6 20 2900 6 220 80 6 19
Par-4D 3270 6 230 4200 6 300 ND 3900 6 330 ND
UV Irradiation 450 6 130 3800 6 250 ND 3700 6 300 ND
NIH-3T3 cells were transfected with pCMV-bgal (2.5 mg) and 5 mg of either plasmid control pCDNA3 (control), pCDNA3-HA-Par-4 (Par-4), or
pCDNA3-HA-Par-4D (Par-4D), together with 10 mg of pCDNA3 (control) pCDNA3-HA-zPKC (zPKC), pCDNA3-HA-zPKCMUT (zPKCMUT), pCDNA3-
HA-l/iPKC(l/iPKC), or pCDNA3-HA-l/iPKCMUT (l/iPKCMUT). Cells were changed 24 hr posttransfection to 0.5% serum–containing medium for
12 hr, after which they were fixed and stained with X-Gal. In other experiments, cells were induced to undergo apoptosis by UV irradiation
and 12 hr afterwards were fixed and stained as above. Results (number of blue cells per 35 mm dish) are the mean 6 SD of three independent
experiments with incubations in duplicate. ND, not determined.
apoptosis. This is illustrated in the experiment in Figure
7, where NIH-3T3 cells were transfected with the
epitope-tagged HA-par-4 expression vector, 24 hr post-
transfection cells were reacted with the anti-HA anti-
body, and DNA was stained with Hoechst 33258. Par-4-
expressing cells displayed a morphology consistent
with apoptosis (Figure 7A, arrow) that includes apoptotic
nuclei (Figure 7B, arrow). Nonfluorescent cells showed
a completelynormal morphology (Figures 7Aand 7B). To
determine whether overexpression of an atypical PKC
overcomes the induction of apoptosis by Par-4, we co-
transfected NIH-3T3 cells with the HA-par-4 expression
vector along with a 3-fold excess of a plasmid that ex-
presses wild-type l/iPKC. Under these conditions, a
clear suppression of the apoptotic phenotype was ob-
served (Figures 7C and 7D). Transfection of wild-type
l/iPKC alone produced no effects (Figures 7E and 7F),
whereas the transfection of kinase-inactive l/iPKC in-
duced apoptosis (Figures 7G and 7H). The results in
Figure 3E are consistent with the proposed role of the
atypical PKCs in apoptosis. Thus, the induction of
apoptosis by UV irradiation leads to a dramatic reduc-
tion of the zPKC enzymatic activity. Interestingly, trans-
fection of wild-type l/iPKC suppresses the induction of
apoptosis by UV irradiation (Table 3).
Figure 7. Morphological Changes Induced by Par-4 Expression
NIH-3T3 cells were transfected with 5 mg of pCDNA3-HA-Par-4 plus
15 mg of pRcCMV plasmids (A and B); with 5 mg of pCDNA3-HA-
Par-4 plus 15 mg of pRcCMV-l/iPKC plasmids (C and D); with 5 mg
of pCDNA3 plus 15 mg of pCDNA3-HA-l/iPKC (E and F); or with 5
mg of pCDNA3 plus 15 mg of pCDNA3-HA-l/iPKCMUT (G and H).
Cells were changed 24 hr posttransfection to 1% serum–containing
medium for 12 hr, after which cells were immunostained with anti-
HA antibody (A, C, E, and G) or Hoechst 3358 (B, D, F, and H).
Essentially identical results were obtained in another three experi-
Figure 6. Induction of Apoptotic DNA Damage by Par-4 and l/iP-
ments.
KCMUT
NIH-3T3 cells were transfected with 20 mg of either control plasmid
or expression vectors for par-4, par-4D, l/iPKC, l/iPKCMUT, par-4 Discussion
plus l/iPKC, or par-4 plus aPKC. Transfection mixture was normal-
ized to 40 mg of total plasmid DNA. Laddered electrophoretic pat-
The different PKC isoforms are targets of important lipidterns of oligonucleosomal DNA fragments were resolved 36 hr post-
second messengers. Thus, diacylglycerol is a major co-transfection by agarose gel electrophoresis. Essentially identical
results were obtained in another two experiments. factor of the classical and novel isotypes (Nishizuka,
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1992), whereasceramide activates the atypicals (Lozano HeLa cell line. In those cells, Par-4 is not associated
with zPKC unless cells are treated with an apoptoticet al., 1994; Mu¨ller et al., 1995), which are also stimulated
in vitro by phosphatidylinositol (3,4,5)trisphosphate (Na- stimulus, such as UV light, that triggers the association
of the preexisting Par-4 with zPKC. This correlates withkanishi et al., 1993). Recently,Ohno and colleagues have
demonstrated in vivo that the atypical PKC isoform a dramatic reduction of its enzymatic activity (M. M. M.,
J. M., and M. T. D.-M., unpublished data). Therefore, itlPKC, and possibly also zPKC, are decisive steps down-
stream of PI 3-kinase in the mitogenic cascade (Akimoto seems that cells that are able to live in the presence of
Par-4 have mechanisms that prevent its interaction withet al., 1996). Interestingly, overexpression of zPKC or
lPKC results in an enhancement of AP1-dependent pro- zPKC. Under these conditions, the apoptotic stimulus
may lead to the inactivation of that mechanism. Alterna-moter activity, which is severely inhibited by expression
of a dominant-negative mutant of lPKC (Akimoto et al., tively, a signal could be required for the Par-4–zPKC
interaction to occur. Therefore, UV irradiation, besides1996). This is clearly consistent with the proposed role
of the atypical PKCs in mitogenic signaling (Berra et al., inducing the expression of Par-4 in NIH-3T3 cells, may
trigger the mechanism that allows the interaction of1993, 1995; Bjorkoy et al., 1995; Diaz-Meco et al., 1996).
On the other hand, the activation of the atypical PKCs Par-4 with zPKC. Par-4 binding to zPKC in transfection
experiments may be due to the fact that overexpressionby ceramideappears to beof functional relevance. Thus,
ceramide is a potent activator of NF-kB (Schu¨tze et al., of the protein lowers the requirement of the second
signal necessary for this binding to occur in a more1992; Yang et al., 1993), and it has been shown that
expression of a dominant-negative mutant of the atypi- physiological environment. Ceramide also activates this
association in HeLa cells (data not shown), suggestingcal PKCs severely impairs kB-dependent promoter acti-
vation by sphingomyelinase (Lozano et al., 1994). Taken the bifunctional role of this lipid second messenger.
Thus, it transiently activates zPKC at early times of celltogether, these findings suggest that the stimulation of
the atypical PKCs by different lipid second messengers activation, whereas at later times it promotes the associ-
ation of zPKC with Par-4. Because ceramide binds di-has important functional consequences. However, al-
though critical, these lipid mediators do not appear to rectly to zPKC but only activates it at low concentrations
(Mu¨ller et al., 1995), it is possible that high levels ofbe selective (see Introduction). We reasoned that the
existence of substantial differences in the regulatory ceramide produced at relatively later times induce a
conformational change in zPKC that makes it competentdomains of the different PKC isotypes should permit
the isolation of potentially selective activators of the to interact with Par-4, leading to its enzymatic inactiva-
tion, which is required for apoptosis to proceed. There-different PKCs by the two-hybrid system in yeast. Fol-
lowing this experimental approach, we have recently fore, ceramide emerges as a bifunctional molecule that
activates both NF-kB and MAPK, on the one hand, andsucceeded in the identification of a novel protein, termed
LIP, that specifically interacts with the regulatory do- apoptosis on the other. TRADD, a novel TNFR1-associ-
ated protein, is another interesting example of a bifunc-main of l/iPKC but not with many other structurally and
functionally related kinases, including zPKC (Diaz-Meco tional messenger (Hsu et al., 1996).
Expression of Par-4 inhibits AP1 promoter activationet al., 1996). What is really interesting about LIP is that
it specifically activates l/iPKC but not zPKC in vitro as in a l/iPKC- and zPKC-dependent manner. Preliminary
unpublished results from this laboratory demonstratewell as in vivo and that its association with this PKC is
dramatically activated following the mitogenic stimula- that expression of Par-4 inhibits MAPK, which may ac-
count for the effects on AP1 promoter activity, and aretion of quiescent cells. Therefore, selective regulation of
the different PKCs could bemediated by protein–protein consistent with the recently suggested role of the atypi-
cal PKCs in the activation of MAPK (Berra et al., 1995).interactions.
In the study reported here, we identify Par-4 as a Inhibition of MAPK has been proposed to be important
for induction of cell death (Xia et al., 1995). On the othernovel and selective inhibitor of both l/iPKC and zPKC.
Although a number of PKC-interacting proteins have hand, PI 3-kinase plays a critical role in the generation
of cell survival signals (Yao and Cooper, 1995). The factrecently been identified (Klauck et al., 1996; Konishi et
al., 1994; Mochly-Rosen et al., 1991; Ron et al., 1994; that theatypical PKCsappear to be located downstream
of that enzyme (Akimoto et al., 1996; Nakanishi et al.,Staudinger et al., 1995), only LIP (Diaz-Meco et al., 1996)
and Par-4 have been shown to interact with the zinc 1993) is potentially of great relevance. Since PI 3-kinase–
derived second messengers activate several kinasesfinger domain of the atypical PKCs and have effects on
their kinase activities. Interestingly, the triggering of the (see above), a critical question is the relative role of the
atypical PKCs compared with the other effectors in theapoptotic pathway promotes the induction of Par-4
(Sells et al., 1994), which according to the data pre- control of cell survival. The fact that Par-4 induces
apoptosis most probably through inhibition of zPKC andsented here binds to and inhibits zPKC as well as
l/iPKC. This suggests that the atypical PKCs are sub- l/iPKC suggests that the atypical PKCs may be at least
one of the relevant transducers of PI 3-kinase–derivedjected to a finely tuned balance of positive and negative
signals that modulate their enzymatic activities through survival signals. It has recently been reported that the
activation of apoptosis triggers the proteolytic stimula-the binding of different protein regulators to the zinc
finger region. Although we and others (Sells et al., 1994) tion of dPKC (Emoto et al., 1995), the growth-inhibitory
properties of which have been documented (Watanabehave found that apoptotic stimuli induce the production
of Par-4, we have found at least one example where et al., 1992). Collectively, these results indicate that dif-
ferent PKC isotypes are critical players in the control ofPar-4 is expressed constitutively. That is the case of the
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cloned into BamHI–EcoRI-digested pGEX-2TK. To generateprogrammed cell death. The precise mechanisms un-
pcDNA3-HA-Par-4, an EcoRV–XbaI fragment excised from pBlues-derlying the interactions among 39-phosphoinositides,
cript–Par-4 was subcloned into EcoRV–XbaI sites of pcDNA3-HA.Par-4, and the atypical PKCs are not clear at this mo-
pcDNA3-HA-Par-4D was obtained by PCR using pBluescript–Par-
ment and will be a matter for future studies. 4 as a template and the following primers: 59-ATTAACCCTCACTA
An interesting aspect of the work presented here and AAG-39 and 59-GCTCTAGATCATTTCCAGTGTGCTACTTG-39. The
PCR product was digested with EcoRV and XbaI and subclonedthat on LIP (Diaz-Meco et al., 1996) is the fact that both
into the same sites of pcDNA3-HA. pGEX-2TK constructs wereLIP and Par-4 bind to the same region in l/iPKC yet do
transformed into E. coli JM101, and expression of GST fusion pro-not display an apparent homology at the amino acid
teins and their purification on glutathione–Sepharose were carriedlevel. It is possible that similar secondary or tertiary
out according to the procedures recommended by the manufac-
structures (or both) in LIP and Par-4 could account for turer. Par-4 was inserted in the EcoRI site of pMALc2 (New England
their ability to interact with the zinc finger of l/iPKC. In Biolabs). Par-4D was amplified by PCR using pGAD-Par-4 as a tem-
plate and the following primers: 59-TACCACTACAATGGATG-39 andthis regard, the PKC-binding domains of LIP and Par-4
59-GCTCTAGATCATTTCCAGTGTGCTACTTG-39. The PCR producthave coiled-coil structures that may be important for
was digested with EcoRI and XbaI and subcloned into pMALc2.that interaction. Further work should clarify this point,
MBP–Par-4 and MBP–Par-4D fusion proteins were expressed in E.as well as the mechanism whereby LIP and Par-4 con-
coli and purified by binding to an amylose resin according to the
nect l/iPKC and zPKC to upstream signaling molecules procedures recommended by the manufacturer. Expression and
and cytokine receptors. In any case, the data presented purification of hnRNPA1 have been previously described (Diaz-
Meco et al., 1996).here further support the role of the atypical PKCs in cell
growth and strongly suggest that the selective modula-
Binding Studiestion of the different PKC isotypes will be mediated by
Purified MBP, MBP–Par-4, or MBP–Par-4D (400 nM) were incubatedprotein–protein interactions. The role of the lipid media-
with in vitro translated 35S-labeled zPKC at 48C for 1 hr. The recombi-tors in this scenario could be to act as cofactors that
nant proteins were recovered on amylose beads, which were
allow or impede the binding of the atypical PKCs to their washed eight times with binding buffer and eluted with 10 mM
respective protein regulators. maltose, and the eluates were fractionated by SDS–PAGE followed
by autoradiography in an InstantImager.
Purified GST or GST fusion proteins encoding the regulatory do-Experimental Procedures
main of zPKC(GST–zPKCREG) or thezinc finger mutant (GST–zPKCREG-
C167S) at a concentration of 800 nM were incubated with either 100 orTwo-Hybrid Screening and cDNA Isolation
400 nM MBP fusion proteins for 1 hr at 48C according to a previouslyFor the yeast two-hybrid screening, pBTM116zPKCREG was cotrans-
published procedure (Diaz-Meco et al., 1996), after which the MBPformed with the human placenta cDNA Matchmaker library in the
fusion proteins were immobilized on amylose resin. After extensivepGAD10 vector (Clontech Laboratories) into the L40 yeast strain,
washing, bound MBP fusion proteins and any associated proteinsand the transformants were plated to synthetic medium lacking
were boiled in sample buffer, fractionated by SDS–PAGE, and immu-histidine, leucine, and tryptophan and containing 20 mM 3-amino-
noblotted with anti-GST antibody to detect binding of the different1,2,4,triazole. The plates were incubated at 308C for 5 days. His1
GST fusion proteins.colonies were assayed for b-galactosidase activity by a filter assay
COS cells were transfected with either control plasmid or an ex-as described below. Oligonucleotides were synthesized by Isogen
pression vector for HA-tagged zPKC or l/iPKC (pCDNA3-HA-zPKCBiosciences (The Netherlands). pBTM116zPKCREG, containing the
or pCDNA3-HA-l/iPKC), after which they were made quiescent byrat brain zPKC regulatory domain, was constructed by polymerase
serum starvation, and the expressed proteins were immunoprecipi-chain reaction (PCR) with the oligonucleotides 59-GGAGAATTCATG
tated with an anti-HA antibody as described previously (Diaz-MecoCCCAGCAGGACC-39 and 59-AGGAATTCTCACTGAGAGATTTTGAT
et al., 1996). Afterward, we determined the effect of 1 mg of MBP,CCCATC-39 and subcloned into the EcoRI site of pBTM116 vector.
MBP–Par-4, or MBP–Par-4D on the unstimulated or phosphatidyl-DNA sequencing was done by the dideoxynucleotide chain termina-
serine-activated (50 mg/ml) enzymatic activity of HA-zPKC. The ac-tion method.
tivity of zPKC was measured essentially as described previously
(Diaz-Meco et al., 1996) using hnRNPA1 as substrate. A similarb-Galactosidase Filter Assays
experiment was performed with a highly purified preparation of clas-Yeast strains were patched to synthetic medium lacking leucine and
sical PKC (Boehringer Mannheim).tryptophan, incubated for 3 days at 308C, and then transferred to a
nitrocellulose filter. The filter was placed in an aluminum foil atop
a sea of liquid nitrogen for 20 s and then immersed in liquid nitrogen Cellular Studies
for 1–2 s. The filter was allowed to come to room temperature and Subconfluent cultures of COS cells in 100 mm plates were
then was placed on top of Whatman 1 paper that had been prewet transfected by the calcium phosphate method (GIBCO BRL) with
in Z buffer containing 0.75 mg/ml 5-bromo-4-chloro-3-indolyl-b-D- 20 mg of either pCDNA3 (control), pCDNA3-HA-Par-4 (HA-Par-4), or
galactoside. The filters were incubated for 3 hr at 308C. Blue color- pCDNA3-HA-Par-4D (HA-Par-4D). Plasmid DNA was removed 4 hr
ation is indicative of b-galactosidase activity. later, and cells were incubated in Dulbecco’s modified Eagle’s me-
dium (DMEM) containing 10% fetal calf serum (FCS) for 36 hr. Cul-
tures were then extracted with lysis buffer (50 mM Tris [pH 7.5], 150Plasmids
pYTH9l/iPKC, pYTH9l/iPKCREG, pYTH9zPKCREG-C167S, pYTH9l/ mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM EGTA, and protease
inhibitors), and extracts were immunoprecipitated with 2 mg of anti-iPKC126, pYTH9l/iPKCZF, pYTH9zPKC, pYTH9zPKCREG, pYTH9z
PKC126, pYTH9zPKCZF, pYTH9aPKCREG, pYTH9ePKCREG, pGBT9- HA antibody (12CA5; Boehringer Mannheim) per milligram of protein
extract. Immunoprecipitates were resolved by SDS–PAGE and im-RafREG, pGBT9Raf, pGBT9RafCAT, pGBT9Mos, pGBT9Lamin,
pCDNA3-HA-zPKC, pCDNA3-HA-l/iPKC, pCDNA3-HA-zPKCMUT, munoblotted with anti-zPKC or anti-aPKC antibodies (GIBCO BRL).
In another set of experiments, NIH-3T3 cells were transfectedpCDNA3-HA-l/iPKCMUT, GST–zPKCREG, GST–l/iPKCREG, and
pRcCMVl/iPKC have previously been described (Berra et al., 1995; with 5 mg of pCDNA3-HA-Par-4 plus 15 mg of pRcCMV plasmids or
with 5 mg of pCDNA3-HA-Par-4 plus 15 mg of pRcCMV-l/iPKCDiaz-Meco et al., 1996). The aPKC expression vector was obtained
by insertion of the full-length cDNA of aPKC into the pMT-2 vector. plasmids, or with 5 mg of pCDNA3 plus 15 mg of pCDNA3-HA-l/
iPKC or with 5 mg of pCDNA3 plus 15 mg of pCDNA3-HA-l/iPKCMUT.GST–zPKCREG-C167S was made by PCR using pYTH9zPKCREG-C167S as a
template and the following primers: 59-ATTGGATCCAGCAGGACCG Cells were changed 24 hr posttransfection to 1% serum–containing
medium for 12 hr, after which cells were immunostained with anti-ACCCCAA-39 and 59-AGGAATTCTCACTGAGAGATTTTGATCCC
ATC-39. The PCR product was digested with BamHI and EcoRI and HA antibody or Hoechst 3358.
Atypical PKCs and Apoptosis
785
Cell viability assays were performed in NIH-3T3 cells that were Bjorkoy, G., Overvatn, A., Dı´az-Meco, M.T., Moscat, J., and Jo-
hansen, T. (1995). Evidence for a bifurcation of the mitogenic signal-transfected with pCMV-bgal (2.5 mg) and 5 mg of either plasmid
control pCDNA3, pCDNA3-HA-Par-4, or pCDNA3-HA-Par-4D, to- ing pathway activated by ras and phosphatidylcholine-hydrolyzing.
J. Biol. Chem. 270, 21299–21306.gether with 10 mg of pCDNA3, pCDNA3-HA-zPKC, pCDNA3-HA-
zPKCMUT, pCDNA3-HA-l/iPKC, or pCDNA3-HA-l/iPKCMUT. Cells Brancolini, C., Benedetti, M., andSchneider, C. (1995). Microfilament
were changed 24 hr posttransfection to 0.5% serum–containing reorganization during apoptosis: the role of Gas-2, a possible sub-
medium for 12 hr, after which they were fixed and stained with strate for ICE-like proteases. EMBO J. 14, 5179–5190.
X-Gal, and the number of blue cells per 35 mm dish was determined
Chinnaiyan, A.M., O’Rourke, K., Tewari, M., and Dixit, V.M. (1995).microscopically.
FADD, a novel death domain-containing protein, interacts with theSubconfluent cultures of NIH-3T3 cells were transfected with dif-
death domain of Fas and initiates apoptosis. Cell 81, 505–512.ferent amounts of plasmid pCDNA3-HA-par-4 or pCDNA3-HA-par-
Cleveland, J.L., and Ihle, J.N. (1995). Contenders in FasL/TNF death4D, together with 500 ng of either 3AP1-Luc or CMV-Luc reporter
signaling. Cell 81, 479–482.plasmids either with or without expression vectors for wild-type
l/iPKC or aPKC. After 4 hr, the DNA-containing medium was re- Diaz-Meco, M.T., Berra, E., Municio, M.M., Sanz, L., Lozano, J.,
moved and cells were made quiescent by serum starvation (0.5%) Dominguez, I., Diaz-Golpe, V., Lain de Lera, M.T., Alcamı´, J., Paya´,
for 24 hr. Afterward, cells were either untreated or stimulated with C.V., Arenzana-Seisdedos, F., Virelizier, J.L., and Moscat, J. (1993).
20% FCS for 4 hr. Extracts were prepared and luciferase activity A dominant negative protein kinase C z subspecies blocks NF-kB
was determined as described previously (Diaz-Meco et al., 1996). activation. Mol. Cell. Biol. 13, 4770–4775.
Data are expressed in terms of relative luciferase activity units, Diaz-Meco, M.T., Municio, M.M., Sanchez, P., Lozano, J., and Mos-
calculated as (light emission from experimental sample 2 light emis- cat, J. (1996). l-Interacting protein, a novel protein that specifically
sion of lysis buffer alone)/mg of cellular protein in the sample. interacts with the zinc finger domain of the atypical protein kinase
For UV treatment, culture medium was removed, dishes were C isotype l/i and stimulates its kinase activity in vitro and in vivo.
washed once with PBS and UVC irradiated (180 J/m2), and fresh Mol. Cell. Biol. 16, 105–114.
medium was added to the cells.
Dominguez, I., Diaz-Meco, M.T., Municio, M.M., Berra, E., Garcia deTo assess the apoptotic DNA damage, cells treated according to
Herreros, A., Cornet, M.E., Sanz, L., and Moscat, J. (1992). Evidencethe experiments were collected, rinsed with Ca21- and Mg21-free
for a role of protein kinase C z subspecies in maturation of XenopusPBS, lysed in lysis buffer (10 mM EDTA, 50 mM Tris [pH 8.0], 0.5%
laevis oocytes. Mol. Cell. Biol. 12, 3776–3783.sodium lauryl sarcosine, 0.5 mg of proteinase K per milliliter) and
Dominguez, I., Sanz, L., Arenzana-Seisdedos, F., Diaz-Meco, M.T.,then incubated at 508C for 1 hr. RNase A (0.5 mg/ml) was added,
Virelizier, J.L., and Moscat, J. (1993). Inhibition of protein kinase zand lyses were incubated for an additional hour. DNA was electro-
subspecies blocks the activation of a NF-kB-like activity in Xenopusphoresed in a 1% agarose gel in 0.53 TBE running buffer for 1 hr
laevis oocytes. Mol. Cell. Biol. 13, 1290–1295.at 90 V.
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